Glenmark Pharmaceuticals Limited (NSE:GLENMARK)

India · Delayed Price · Currency is INR

2,173.80

+29.30 (1.37%)

Jun 12, 2026, 3:30 PM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Pharmaceuticals	169.83B	133.63B	126.45B	116.56B	123.05B
Pharmaceuticals Growth	27.08%	5.68%	8.49%	-5.28%	12.44%
Total	169.83B	133.63B	126.45B	116.56B	123.05B
Total Growth	27.08%	5.68%	8.49%	-5.28%	12.44%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
India	44.84B	33.97B	40.46B	43.81B
India Growth	32.02%	-16.05%	-7.64%	10.83%
North America	30.17B	30.94B	31.48B	32.04B
North America Growth	-2.49%	-1.71%	-1.73%	-0.02%
Europe	30.06B	25.56B	20.06B	20.05B
Europe Growth	17.64%	27.42%	0.04%	18.54%
Latin America and Rest of The World	28.14B	27.67B	23.83B	-
Latin America and Rest of The World Growth	1.71%	16.07%	-	-
Latin America	-	-	-	6.13B
Latin America Growth	-	-	-	8.23%
Rest of The World (ROW)	-	-	-	21.03B
Rest of The World (ROW) Growth	-	-	-	37.48%
Total	133.22B	118.13B	115.83B	123.05B
Total Growth	12.77%	1.98%	-5.86%	12.44%